We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Blood Test Can Predict Severity of COVID-19

By LabMedica International staff writers
Posted on 30 Jun 2020
Doctors can now identify COVID-19 patients having the highest risk of severe illness and pinpoint those most likely to need a ventilator by simply examining their blood.

This discovery by researchers from the University of Virginia (UVA) School of Medicine (Charlottesville, VA, USA) could lead to new treatments for the prevention of deadly “cytokine storms” seen in severe cases of COVID-19. More...
It also may help explain why diabetes contributes to worse outcomes in patients with the coronavirus.

Cytokines – proteins produced by immune cells – are responsible for severe overreactions by the immune system, known as cytokine storms, associated with COVID-19 and other serious illnesses. Cytokine storms are typically associated with an established group of cytokines. The researchers identified 57 COVID-19 patients treated at UVA who ultimately required a ventilator and then tested their blood samples within 48 hours of diagnosis or hospital admission. They compared the results with those from patients who did not end up needing a ventilator. The researchers found that the best predictor of COVID-19 outcomes was an “underappreciated” cytokine more associated with allergies. High levels of that cytokine, IL-13, were associated with worsened COVID-19 outcomes regardless of patients’ gender, age or other health problems.

The researchers also identified two more cytokines associated with severe outcomes, though the duo had less ability to predict the need for a ventilator. The researchers say the discovery could become part of a scoring system to let doctors flag up at-risk COVID-19 patients for closer monitoring and personalized interventions. In addition, the researchers found that levels of two other cytokines were significantly higher in patients with elevated blood sugar. This “proinflammatory response” could help explain why diabetes is associated with worse COVID-19 outcomes, according to the researchers.

“The immune response that we discovered to predict severe shortness of breath in COVID-19 is known in other pulmonary diseases to cause damage. So this could lead to a novel way to prevent respiratory failure in individuals infected with the new coronavirus, by inhibiting this immune cytokine,” said Bill Petri, MD, PhD, of UVA’s Division of Infectious Diseases and International Health. “We plan to test this in a model of COVID-19 prior to considering a clinical trial.”

Related Links:
University of Virginia School of Medicine


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Portable Electronic Pipette
Mini 96
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.